Cullinan Therapeutics, Inc.
CGEM
$10.50
$0.302.94%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.61M | -70.06M | -48.50M | -47.65M | -40.56M |
| Total Depreciation and Amortization | 79.00K | 77.00K | 76.00K | 77.00K | 76.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.11M | 8.18M | 7.06M | 6.12M | 4.50M |
| Change in Net Operating Assets | 5.55M | 4.19M | -1.79M | 4.82M | 1.84M |
| Cash from Operations | -36.88M | -57.61M | -43.16M | -36.63M | -34.14M |
| Capital Expenditure | -38.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 67.43M | 53.40M | 36.81M | 15.96M | 19.88M |
| Cash from Investing | 67.39M | 53.40M | 36.81M | 15.96M | 19.88M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 373.00K | -- | 1.58M | 1.98M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -656.00K |
| Cash from Financing | 0.00 | 373.00K | -- | 1.58M | 1.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 30.52M | -3.84M | -6.35M | -19.08M | -12.94M |